Skip to main content
. 2015 May 15;109(4):343–352. doi: 10.1111/vox.12287

Table 3.

PCT-PLT component characteristics

HV study Patients Transfusion episodes % Buffy coat % Apheresis % γ-Irradiated % HLA matched
HV1 10 651 5106 8·0 92·0 2·7 3·1
HV2 9 1400 7437 35·2 64·8 1·1 2·5
HV3 2016 6632 58·8 41·2 5·3 0·3
Total 4067 19 175 36·1 63·9 3·0 1·9

HLA, human leucocyte antigen; HV, haemovigilance.